Current as of 2026
For too long, efforts to improve maternal health have often begun only once a woman becomes pregnant. By then, an important opportunity to protect her health, and the health of a future baby, may already have been missed.
We spoke with Professor Nike Bello, National Coordinator of the WOMAN-3 Trial in Nigeria and obstetrician at University College Hospital Ibadan, about why preventing, detecting and treating anemia earlier in women’s lives matters.
The WOMAN-3 Trial is an international randomized, placebo-controlled trial taking place in Nigeria, Pakistan and Tanzania. The trial, led by Professor Nike Bello and Professor Oladapo Olayemi, aims to determine whether oral tranexamic acid (TXA), taken during menstruation in adult women, alongside iron and vitamin supplements, is more effective at treating anemia than with supplements alone. Screening in Nigeria began in June 2026, and the team has already recruited 300 participants.